Long-term Results of Ponatinib in CP-CML: 4-Year Minimum Follow-up of a Phase 1 Trial
Titel:
Long-term Results of Ponatinib in CP-CML: 4-Year Minimum Follow-up of a Phase 1 Trial
Auteur:
Kantarjian, Hagop M. Talpaz, Moshe Cortes, Jorge E. Shah, Neil P. Bixby, Dale L. Flinn, Ian W. O’Hare, Thomas J. Hu, Simin Rivera, Victor M. Clackson, Tim Conlan, Maureen G. Haluska, Frank G. Druker, Brian J. Deininger, Michael W. Mauro, Michael J.